This primary in silico work provided strong evidence that AHNAK2 may have a link with tumour growth, oncogenesis, and disease progression in ccRCC, which is further elucidated through in vitro and in vivo experiments. This evidence concerns the gene AHNAK2 and nonpapillary renal cell carcinoma.